“Cure App Co., Ltd.”which conducts research and development for "Treatment Applications®" issued a third-party allocation of new shares to a total of about 1.5 billion yen
To the press and whom it may concern: “ Cure App Co., Ltd. ” which conducts research and development for "Treatment Applications ® " issued a third-party allocation of new shares to a total of about 1.5 billion yen Cure App Co., Ltd. (Head office: Chuo , Tokyo. President and CEO: Kota Satake), which conducts research and development for medical treatment applications for the treatment of disorders, announced today that they are implementing a third-party allocation of new shares of over 1.5 billion yen with newly acquired investors: the ITOCHU Corporation, ITOCHU Technology Ventures, CYBERDYNE Corporation, Dai-ichi Life Insurance Co., Ltd., Mitsubishi UFJ Capital Co., Ltd., Iwashin Business Creation Capital Co., Ltd., Saison Ventures Co., Ltd. (Credit Saison corporate Venture Capital), Chibagin Capital Corporation, Mizuho Capital Corporation in addition to our existing investors, Beyond Next Ventures and